Nahi H - Search Results

1

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.

Deneberg S, Grövdal M, Karimi M, Jansson M, Nahi H, Corbacioglu A, Gaidzik V, Döhner K, Paul C, Ekström TJ, Hellström-Lindberg E, Lehmann S. Deneberg S, et al. Among authors: nahi h. Leukemia. 2010 May;24(5):932-41. doi: 10.1038/leu.2010.41. Epub 2010 Mar 18. Leukemia. 2010. PMID: 20237504

2

[No title available]

[No authors listed] [No authors listed] PMID: 37132225

3

Potential value of pre-planned imaging of bone disease in multiple myeloma.

Gundesen MT, Asmussen JT, Schjesvold F, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Teodorescu EM, Jensen BA, Slørdahl TS, Nahi H, Waage A, Abildgaard N, Lund T; Nordic Myeloma Study Group. Gundesen MT, et al. Among authors: nahi h. Blood Cancer J. 2023 Jul 7;13(1):105. doi: 10.1038/s41408-023-00880-0. Blood Cancer J. 2023. PMID: 37419876 Free PMC article. No abstract available.

4

Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion.

Nahi H, Lehmann S, Mollgard L, Bengtzen S, Selivanova G, Wiman KG, Paul C, Merup M. Nahi H, et al. Br J Haematol. 2004 Nov;127(3):285-91. doi: 10.1111/j.1365-2141.2004.05210.x. Br J Haematol. 2004. PMID: 15491287 Free article.

5

PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion.

Nahi H, Merup M, Lehmann S, Bengtzen S, Möllgård L, Selivanova G, Wiman KG, Paul C. Nahi H, et al. Br J Haematol. 2006 Jan;132(2):230-6. doi: 10.1111/j.1365-2141.2005.05851.x. Br J Haematol. 2006. PMID: 16398657 Free article.

6

Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia.

Uggla B, Tina E, Nahi H, Paul C, Höglund M, Sirsjö A, Tidefelt U. Uggla B, et al. Among authors: nahi h. Int J Oncol. 2007 Jul;31(1):153-60. Int J Oncol. 2007. PMID: 17549416

7

The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia.

Möllgård L, Deneberg S, Nahi H, Bengtzen S, Jonsson-Videsäter K, Fioretos T, Andersson A, Paul C, Lehmann S. Möllgård L, et al. Among authors: nahi h. Cancer Chemother Pharmacol. 2008 Aug;62(3):439-48. doi: 10.1007/s00280-007-0623-4. Epub 2007 Oct 25. Cancer Chemother Pharmacol. 2008. PMID: 17960382

8

Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.

Nahi H, Lehmann S, Bengtzen S, Jansson M, Möllgård L, Paul C, Merup M. Nahi H, et al. Leuk Lymphoma. 2008 Mar;49(3):508-16. doi: 10.1080/10428190701861645. Leuk Lymphoma. 2008. PMID: 18297528

9

Mutated and non-mutated TP53 as targets in the treatment of leukaemia.

Nahi H, Selivanova G, Lehmann S, Möllgård L, Bengtzen S, Concha H, Svensson A, Wiman KG, Merup M, Paul C. Nahi H, et al. Br J Haematol. 2008 May;141(4):445-53. doi: 10.1111/j.1365-2141.2008.07046.x. Epub 2008 Mar 12. Br J Haematol. 2008. PMID: 18341636 Free article.

10

Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation.

Paul E, Sutlu T, Deneberg S, Alici E, Björkstrand B, Jansson M, Lerner R, Wallblom A, Gahrton G, Nahi H. Paul E, et al. Among authors: nahi h. Oncol Rep. 2009 Jul;22(1):137-42. doi: 10.3892/or_00000416. Oncol Rep. 2009. PMID: 19513515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page